NM_002755.4:c.175_177delAAG
Variant summary
Our verdict is Pathogenic. The variant received 13 ACMG points: 13P and 0B. PM1PM2PM4_SupportingPP5_Very_Strong
The NM_002755.4(MAP2K1):c.175_177delAAG(p.Lys59del) variant causes a conservative inframe deletion change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Likely pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. K59K) has been classified as Likely benign.
Frequency
Consequence
NM_002755.4 conservative_inframe_deletion
Scores
Clinical Significance
Conservation
Publications
- cardiofaciocutaneous syndromeInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
- cardiofaciocutaneous syndrome 3Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae), PanelApp Australia, Genomics England PanelApp
- Noonan syndrome with multiple lentiginesInheritance: AD Classification: STRONG, LIMITED Submitted by: Genomics England PanelApp, ClinGen
- Noonan syndromeInheritance: AD Classification: LIMITED Submitted by: ClinGen
- Costello syndromeInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 13 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| MAP2K1 | NM_002755.4 | c.175_177delAAG | p.Lys59del | conservative_inframe_deletion | Exon 2 of 11 | ENST00000307102.10 | NP_002746.1 | |
| MAP2K1 | NM_001411065.1 | c.109_111delAAG | p.Lys37del | conservative_inframe_deletion | Exon 2 of 10 | NP_001397994.1 | ||
| MAP2K1 | XM_011521783.4 | c.109_111delAAG | p.Lys37del | conservative_inframe_deletion | Exon 2 of 11 | XP_011520085.1 | ||
| MAP2K1 | XM_017022411.3 | c.175_177delAAG | p.Lys59del | conservative_inframe_deletion | Exon 2 of 10 | XP_016877900.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| MAP2K1 | ENST00000307102.10 | c.175_177delAAG | p.Lys59del | conservative_inframe_deletion | Exon 2 of 11 | 1 | NM_002755.4 | ENSP00000302486.5 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not provided Pathogenic:2
- -
In-frame deletion of one amino acid in a non-repeat region; In silico analysis supports a deleterious effect on protein structure/function; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 29753091, 17551924) -
Cardiofaciocutaneous syndrome 3 Pathogenic:1
- -
RASopathy Pathogenic:1
In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. This variant, c.175_177del, results in the deletion of 1 amino acid(s) of the MAP2K1 protein (p.Lys59del), but otherwise preserves the integrity of the reading frame. This variant is not present in population databases (gnomAD no frequency). This variant has been observed in individual(s) with cardio-facio-cutaneous syndrome (PMID: 17551924). In at least one individual the variant was observed to be de novo. ClinVar contains an entry for this variant (Variation ID: 222074). Algorithms developed to predict the effect of variants on protein structure and function are not available or were not evaluated for this variant. Experimental studies have shown that this variant affects MAP2K1 function (PMID: 29753091). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at